REG-GSK Plc: Director/PDMR Shareholding
Yesterday 11:00
GSK plc (the ‘Company’)
Transaction notification
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Emma Walmsley
b) Position/status Chief Executive Officer
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 9 (partnership shares)
£14.9465 9 (matching shares)
d) Aggregated information
Aggregated volume Price 18 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Julie Brown
b) Position/status Chief Financial Officer
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name James Ford
b) Position/status SVP and Group General Counsel, Legal and Compliance
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Sally Jackson
b) Position/status SVP, Global Communications and CEO Office
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name David Redfern
b) Position/status President, Corporate Development
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Regis Simard
b) Position/status President, Global Supply Chain
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Philip Thomson
b) Position/status President, Global Affairs
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Deborah Waterhouse
b) Position/status CEO, ViiV Healthcare and President, Global Health, GSK
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
1. Details of PDMR/person closely associated with them (‘PCA’)
a) Name Victoria Whyte
b) Position/status Company Secretary
c) Initial notification/ amendment Initial notification
2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each (‘Ordinary Shares’) ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares under the Company’s Share Reward Plan
c) Price(s) and volume(s) Price(s) Volume(s)
£14.9465 8 (partnership shares)
£14.9465 8 (matching shares)
d) Aggregated information
Aggregated volume Price 16 Ordinary Shares £14.9465
e) Date of the transaction 2025-06-10
f) Place of the transaction London Stock Exchange (XLON)
Copyright (c) 2025 PR Newswire Association,LLC. All Rights ReservedRecent news on GSK
See all newsREG - GSK PLC - GSK submits Arexvy for adults 18+ with EMA
AnnouncementREG - GSK PLC - Transaction in Own Shares
AnnouncementREG-GSK Plc: Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Transaction in Own Shares
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
Announcement